In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway
Objectives: Danzhi Jiangtang capsule (DJC) is widely used for preventing and treating diabetic cardiomyopathy (DCM). However, the underlying mechanisms of the anti-inflammatory and antiapoptotic activities are unclear. Methods: In the in vivo diabetic cardiomyopathy rat model, cardiac function was m...
Saved in:
Main Authors: | Hui Shi (Author), Peng Zhou (Author), Ying-qun Ni (Author), Shu-shu Wang (Author), Rui Song (Author), An-lu Shen (Author), Zhao-hui Fang (Author), Liang Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of TLR4-MyD88 and NF-κB in the Iris during Endotoxin-Induced Uveitis
by: Shang Li, et al.
Published: (2010) -
Wedelolactone Mitigates Alcoholic Steatohepatitis via Modulating the TLR4/MyD88/NF-κB Pathway
by: Tao Jiang, et al.
Published: (2024) -
Zhuifeng tougu capsules inhibit the TLR4/MyD88/NF-κB signaling pathway and alleviate knee osteoarthritis: In vitro and in vivo experiments
by: Xiaotong Xu, et al.
Published: (2022) -
Oxymatrine Downregulates TLR4, TLR2, MyD88, and NF-κB and Protects Rat Brains against Focal Ischemia
by: Hongguang Fan, et al.
Published: (2009) -
Radix pseudostellariae of Danzhi Jiangtang capsule relieves oxidative stress of vascular endothelium in diabetic macroangiopathy
by: Zhaohui Fang, et al.
Published: (2020)